Cargando…

Influence of Drug-Carrier Polymers on Alpha-Synucleinopathies: A Neglected Aspect in New Therapies Development

Current therapeutic strategies to treat neurodegenerative diseases, such as alpha-synucleinopathies, aim at enhancing the amount of drug reaching the brain. Methods proposed, such as intranasal administration, should be able to bypass the blood brain barrier (BBB) and even when directly intracerebra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tonda-Turo, C., Herva, M., Chiono, V., Ciardelli, G., Spillantini, M. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852847/ https://www.ncbi.nlm.nih.gov/pubmed/29686999 http://dx.doi.org/10.1155/2018/4518060

Ejemplares similares

Quartz Crystal Microbalance With Dissipation Monitoring: A Powerful Method to Predict the in vivo Behavior of Bioengineered Surfaces
por: Tonda-Turo, Chiara, et al.
Publicado: (2018)

Biocompatible Electrospun Polycaprolactone-Polyaniline Scaffold Treated with Atmospheric Plasma to Improve Hydrophilicity
por: Licciardello, Michela, et al.
Publicado: (2021)

Influence of Parathyroid Hormone-Loaded PLGA Nanoparticles in Porous Scaffolds for Bone Regeneration
por: Gentile, Piergiorgio, et al.
Publicado: (2015)

Towards 3D Multi-Layer Scaffolds for Periodontal Tissue Engineering Applications: Addressing Manufacturing and Architectural Challenges
por: Porta, Marta, et al.
Publicado: (2020)

Dual stimuli-responsive polyurethane-based hydrogels as smart drug delivery carriers for the advanced treatment of chronic skin wounds
por: Laurano, Rossella, et al.
Publicado: (2021)

The Synucleinopathies: Twenty Years On
por: Goedert, Michel, et al.
Publicado: (2017)

Gene Therapy to Modulate Alpha-Synuclein in Synucleinopathies
por: Sandoval, Ivette M., et al.
Publicado: (2021)

Plasma Treatment of Polymer Powder as an Effective Tool to Functionalize Polymers: Case Study Application on an Amphiphilic Polyurethane
por: Laurano, Rossella, et al.
Publicado: (2019)

The Role of Glia in Alpha-Synucleinopathies
por: Fellner, Lisa, et al.
Publicado: (2012)

Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies
por: Rcom-H'cheo-Gauthier, Alexandre N., et al.
Publicado: (2016)

Metallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies
por: Okita, Yuho, et al.
Publicado: (2017)

Cardiac Alpha-Synuclein Is Present in Alpha-Synucleinopathies
por: Javanshiri, Keivan, et al.
Publicado: (2022)

The interplay between chondrocyte spheroids and mesenchymal stem cells boosts cartilage regeneration within a 3D natural-based hydrogel
por: Scalzone, Annachiara, et al.
Publicado: (2019)

Pure Autonomic Failure-A Localized Alpha Synucleinopathy with a Potential for Conversion to More Extensive Alpha Synucleinopathies
por: Bhattacharjee, Shakya, et al.
Publicado: (2022)

Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies
por: Fairfoul, Graham, et al.
Publicado: (2016)

Neuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathies
por: Refolo, Violetta, et al.
Publicado: (2019)

The Effect of Electrospun Gelatin Fibers Alignment on Schwann Cell and Axon Behavior and Organization in the Perspective of Artificial Nerve Design
por: Gnavi, Sara, et al.
Publicado: (2015)

Chemical disaggregation of alpha-synuclein fibrils as a therapy for synucleinopathies
por: Wu, Shenjie, et al.
Publicado: (2023)

Plant poisoning leads to alpha-synucleinopathy and neuromelanopathy in kangaroos
por: Tayebi, Mourad, et al.
Publicado: (2019)

DLP 3D Printing Meets Lignocellulosic Biopolymers: Carboxymethyl Cellulose Inks for 3D Biocompatible Hydrogels
por: Melilli, Giuseppe, et al.
Publicado: (2020)

Alpha-Synuclein in Skin Nerve Fibers as a Biomarker for Alpha-Synucleinopathies
por: Kim, Jee Young, et al.
Publicado: (2019)

Technological Aspects and Evaluation Methods for Polymer Matrices as Dental Drug Carriers
por: Kida, Dorota, et al.
Publicado: (2023)

Linking the Endoplasmic Reticulum to Parkinson’s Disease and Alpha-Synucleinopathy
por: Colla, Emanuela
Publicado: (2019)

Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
por: Brás, Inês C., et al.
Publicado: (2021)

Viral alpha-synuclein knockdown prevents spreading synucleinopathy
por: Menon, Sindhu, et al.
Publicado: (2021)

Sex differences in alpha-synucleinopathies: a systematic review
por: Raheel, Kausar, et al.
Publicado: (2023)

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities
por: Visanji, Naomi P., et al.
Publicado: (2019)

Alpha-synucleinopathy and neuropsychological symptoms in a population-based cohort of the elderly
por: Zaccai, Julia, et al.
Publicado: (2015)

Embedding Ordered Mesoporous Carbons into Thermosensitive Hydrogels: A Cutting-Edge Strategy to Vehiculate a Cargo and Control Its Release Profile
por: Boffito, Monica, et al.
Publicado: (2020)

In-vitro Characterization of a Hernia Mesh Featuring a Nanostructured Coating
por: Giuntoli, Giulia, et al.
Publicado: (2021)

The role of lysosomes in alpha-synucleinopathies: a focus on glial cells
por: Balta, Denise, et al.
Publicado: (2021)

Senescence and impaired DNA damage responses in alpha-synucleinopathy models
por: Yoon, Ye-Seul, et al.
Publicado: (2022)

Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
por: Menon, Sindhu, et al.
Publicado: (2022)

Exosomes in Alpha-Synucleinopathies: Propagators of Pathology or Potential Candidates for Nanotherapeutics?
por: Mavroeidi, Panagiota, et al.
Publicado: (2022)

Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies
por: Poggiolini, Ilaria, et al.
Publicado: (2021)

Evaluation of alpha-synuclein immunohistochemical methods for the detection of Lewy-type synucleinopathy in gastrointestinal biopsies
por: Corbillé, Anne-Gaëlle, et al.
Publicado: (2016)

Editorial: Methods in nanobiotechnology
por: Gentile, Piergiorgio, et al.
Publicado: (2022)

GBA-Associated Synucleinopathies: Prime Candidates for Alpha-Synuclein Targeting Compounds
por: Brockmann, Kathrin
Publicado: (2020)

Cortical circuit dysfunction in a mouse model of alpha-synucleinopathy in vivo
por: Blumenstock, Sonja, et al.
Publicado: (2021)

Alpha-Synuclein Strain Variability in Body-First and Brain-First Synucleinopathies
por: Just, Mie Kristine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h80svvmu8p61onhu0d9bm124em